Spirulina — Research Profile

What the Research Says

The 2018 metabolic review included 12 trials with 14 arms and doses ranging 1–19 g/day for 2–48 weeks. It reported absolute mean differences, including LDL −33.16 mg/dL, rather than a fixed 16% reduction [1]. A later review that included nine spirulina studies found no significant lipid effect and only a small diastolic-pressure effect of uncertain clinical significance [10]. A separate blood-pressure review reported pooled reductions of 4.41/2.84 mmHg with heterogeneity and moderate certainty [11]. These differing results do not establish spirulina as a reliable lipid treatment.

The allergic-rhinitis trial reported improvement compared with placebo, but did not establish an antihistamine-equivalence claim or a universal response timeline [4]. The senior-citizen study enrolled 40 people and analyzed 30 completers without randomized control. It measured blood indices and IDO activity; it did not demonstrate protection against infection or abnormal cells [3].

Laboratory phycocyanin findings are mechanistic. They do not show that a spirulina supplement acts like a COX-2 medicine without side effects. Clinical usefulness, dose, long-term safety and product contaminants require separate assessment.

Benefits of Spirulina

• Lipids — the 2018 review pooled 12 trials and reported absolute mean lipid differences, including LDL −33.16 mg/dL, not a universal 16% reduction. A later review of nine spirulina studies found no significant lipid effect. The discrepancy limits confidence in a predictable result [1,10].
• Blood pressure — a GRADE-assessed review reported mean changes of −4.41 mmHg systolic and −2.84 mmHg diastolic, with heterogeneity and moderate certainty. These are pooled estimates, not an individual promise or replacement for treatment [11].
• Immune research — the senior-citizen study had 40 enrolled and 30 completers, without a randomized control group. It measured blood counts and IDO activity, not proven NK-cell protection against viruses or abnormal cells [3].
• Allergic rhinitis — a placebo-controlled trial reported symptom improvements, but further research was requested. The cited trial does not establish equivalence to cetirizine or a guaranteed one-to-two-week onset [4].
• Mechanisms — laboratory antioxidant or COX-2 effects of phycocyanin do not establish drug-equivalent anti-inflammatory benefit or absence of gastrointestinal side effects.

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

• Mild GI discomfort (nausea, bloating) — most common, especially at higher doses or initial use
• Green discoloration of stool (harmless)
• Headache reported rarely, usually resolves with dose reduction
• Allergic reactions in individuals sensitive to algae or seaweed
• Contamination risk — spirulina harvested from uncontrolled environments may contain heavy metals, microcystins, or bacteria; always choose quality-tested brands

Drug & Supplement Interactions

• People taking immunosuppressants or receiving autoimmune-disease treatment should consult their specialist; effects on clinical immune outcomes and interactions are incompletely characterized.
• Vitamin K intake is relevant to warfarin management; this mechanism should not be generalized to heparin. Review the exact product and anticoagulant with the treating clinician.
• Glucose- or blood-pressure-lowering effects could matter with related medicines, but the clinical interaction magnitude is not established by these trials.
• Phenylalanine content is a dietary consideration in phenylketonuria, not a generic interaction with PKU medicines. Follow the metabolic-care team’s dietary plan.